The liver maintains blood glucose during fasting through glycogenolysis (enzyme-catalyzed breakdown of stored glycogen) and gluconeogenesis (synthesis of glucose from pyruvate, lactate, amino acids, and glycerol), responding to hormonal signals from epinephrine, glucagon, and cortisol. This hepatic glucose output is critical for preventing hypoglycemia and maintaining brain function.
Your brain consumes about 120 grams of glucose per day and cannot easily switch to alternative fuels in the short term. Yet a typical meal provides glucose for only a few hours before blood levels would begin to fall. The liver solves this problem by acting as the body's glucose bank — storing glucose after meals and releasing it between meals to maintain blood glucose in the narrow range of 70–100 mg/dL. The two withdrawal mechanisms are glycogenolysis (breaking down stored glycogen) and gluconeogenesis (synthesizing new glucose from non-carbohydrate precursors), and they operate on different timescales during fasting.
From your study of carbohydrate homeostasis, you know that the liver stores roughly 80–100 grams of glycogen after a meal. Glycogenolysis is the faster of the two pathways: the enzyme glycogen phosphorylase cleaves glucose-1-phosphate units from glycogen branches, which are then converted to glucose-6-phosphate and finally to free glucose by the enzyme glucose-6-phosphatase — an enzyme that is present in the liver and kidneys but absent from muscle. This is why muscle glycogen fuels muscle contraction but cannot directly contribute to blood glucose: muscle lacks the phosphatase needed to release free glucose into the bloodstream. Hepatic glycogenolysis dominates glucose production during the first 12–18 hours of fasting, but glycogen stores are finite and progressively depleted.
As glycogen reserves decline, gluconeogenesis becomes the primary source of blood glucose. This pathway, which you have encountered through metabolic hormones, synthesizes glucose from lactate (produced by anaerobic glycolysis in muscle and red blood cells), amino acids (especially alanine, mobilized from muscle protein), and glycerol (released from triglyceride breakdown in adipose tissue). Gluconeogenesis is not simply glycolysis in reverse — it bypasses three irreversible glycolytic steps using dedicated enzymes (pyruvate carboxylase, PEP carboxykinase, fructose-1,6-bisphosphatase, and glucose-6-phosphatase). During prolonged fasting beyond 24 hours, gluconeogenesis accounts for essentially all hepatic glucose output.
The hormonal control is straightforward in principle. Glucagon, secreted by pancreatic alpha cells when blood glucose falls, is the primary activator of both glycogenolysis and gluconeogenesis. It acts through cAMP signaling in hepatocytes to activate glycogen phosphorylase and upregulate gluconeogenic enzymes. Epinephrine provides a rapid boost during acute stress, also activating glycogenolysis. Cortisol acts more slowly, promoting gluconeogenesis by increasing substrate availability (amino acids from muscle, glycerol from fat) and upregulating gluconeogenic enzyme expression. Insulin, conversely, suppresses both pathways. The clinical significance is immediate: in type 1 diabetes, the absence of insulin leaves glucagon unopposed, and the liver produces glucose continuously even when blood glucose is already dangerously high — a key reason why diabetic hyperglycemia is so difficult to control without exogenous insulin.